WATERTOWN, Mass., Oct. 30, 2023 EyePoint Pharmaceuticals, Inc. , a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with retinal.
Arcturus Therapeutics Holdings Inc. , a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and.
Focused on advancing ZB-106, a potential first-in-class anti-IL-17 and anti-BAFF dual antagonist for systemic sclerosis and hidradenitis suppurativa
Experienced team building the next immunology. -Today at 07:01 am- MarketScreener
MoonLake Immunotherapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
MoonLake Immunotherapeutics AG: MoonLake Immunotherapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.